Registro:

Referencias:

• Asa, S.L., Kelly, M.A., Grandy, D.K., Low, M.J., Pituitary lactotroph adenomas develop after prolonged lactotroph hyperplasia in dopamine D2 receptor-deficient mice (1999) Endocrinology, 140, pp. 5348-5355
• Asa, S.L., Penz, G., Kovacs, K., Ezrin, C., Prolactin cells in the human pituitary. A quantitative immunocytochemical analysis (1982) Arch. Pathol. Lab. Med., 106, pp. 360-363
• Derynck, R., Akhurst, R.J., Balmain, A., TGF-beta signaling in tumor suppression and cancer progression (2001) Nat. Genet., 29, pp. 117-129
• Derynck, R., Zhang, Y., Feng, X.H., Smads: transcriptional activators of TGF-beta responses (1998) Cell, 95, pp. 737-740
• Faure, M.O., Nicol, L., Fabre, S., Fontaine, J., Mohoric, N., McNeilly, A., Taragnat, C., BMP-4 inhibits follicle-stimulating hormone secretion in ewe pituitary (2005) J. Endocrinol., 186, pp. 109-121
• Gazzerro, E., Canalis, E., Bone morphogenetic proteins and their antagonists (2006) Rev. Endocr. Metab. Disord., 7, pp. 51-65
• Giacomini, D., Paez-Pereda, M., Stalla, J., Stalla, G.K., Arzt, E., Molecular interaction of BMP-4, TGF-beta, and estrogens in lactotrophs: impact on the PRL promoter (2009) Mol. Endocrinol., 23, pp. 1102-1114
• Giacomini, D., Paez-Pereda, M., Theodoropoulou, M., Labeur, M., Refojo, D., Gerez, J., Chervin, A., Arzt, E., Bone morphogenetic protein-4 inhibits corticotroph tumor cells: involvement in the retinoic acid inhibitory action (2006) Endocrinology, 147, pp. 247-256
• Heaney, A.P., Fernando, M., Melmed, S., Functional role of estrogen in pituitary tumor pathogenesis (2002) J. Clin. Invest., 109, pp. 277-283
• Japon, M.A., Rubinstein, M., Low, M.J., In situ hybridization analysis of anterior pituitary hormone gene expression during fetal mouse development (1994) J. Histochem. Cytochem., 42, pp. 1117-1125
• Kahata, K., Hayashi, M., Asaka, M., Hellman, U., Kitagawa, H., Yanagisawa, J., Kato, S., Miyazono, K., Regulation of transforming growth factor-beta and bone morphogenetic protein signaling by transcriptional coactivator GCN5 (2004) Genes Cells, 9, pp. 143-151
• Kawabata, M., Imamura, T., Miyazono, K., Signal transduction by bone morphogenetic proteins (1998) Cytokine Growth Factor Rev., 9, pp. 49-61
• Kelly, M.A., Rubinstein, M., Asa, S.L., Zhang, G., Saez, C., Bunzow, J.R., Allen, R.G., Low, M.J., Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice (1997) Neuron, 19, pp. 103-113
• Lee, K.B., Khivansara, V., Santos, M.M., Lamba, P., Yuen, T., Sealfon, S.C., Bernard, D.J., Bone morphogenetic protein 2 and activin A synergistically stimulate follicle-stimulating hormone beta subunit transcription (2007) J. Mol. Endocrinol., 38, pp. 315-330
• Lohrer, P., Gloddek, J., Hopfner, U., Losa, M., Uhl, E., Pagotto, U., Stalla, G.K., Renner, U., Vascular endothelial growth factor production and regulation in rodent and human pituitary tumor cells in vitro (2001) Neuroendocrinology, 74, pp. 95-105
• Massague, J., TGF-beta signal transduction (1998) Annu. Rev. Biochem., 67, pp. 753-791
• Massague, J., How cells read TGF-beta signals (2000) Nat. Rev. Mol. Cell Biol., 1, pp. 169-178
• Massague, J., Chen, Y.G., Controlling TGF-beta signaling (2000) Genes Dev., 14, pp. 627-644
• Miyazono, K., Maeda, S., Imamura, T., BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk (2005) Cytokine Growth Factor Rev., 16, pp. 251-263
• Miyoshi, T., Otsuka, F., Otani, H., Inagaki, K., Goto, J., Yamashita, M., Ogura, T., Makino, H., Involvement of bone morphogenetic protein-4 in GH regulation by octreotide and bromocriptine in rat pituitary GH3 cells (2008) J. Endocrinol., 197, pp. 159-169
• Nudi, M., Ouimette, J.F., Drouin, J., Bone morphogenic protein (Smad)-mediated repression of proopiomelanocortin transcription by interference with Pitx/Tpit activity (2005) Mol. Endocrinol., 19, pp. 1329-1342
• Onichtchouk, D., Chen, Y.G., Dosch, R., Gawantka, V., Delius, H., Massague, J., Niehrs, C., Silencing of TGF-beta signaling by the pseudoreceptor BAMBI (1999) Nature, 401, pp. 480-485
• Paez-Pereda, M., Giacomini, D., Refojo, D., Nagashima, A.C., Hopfner, U., Grubler, Y., Chervin, A., Arzt, E., Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk (2003) Proc. Natl. Acad. Sci. U.S.A., 100, pp. 1034-1039
• Paez-Pereda, M., Kovalovsky, D., Hopfner, U., Theodoropoulou, M., Pagotto, U., Uhl, E., Losa, M., Stalla, G.K., Retinoic acid prevents experimental Cushing syndrome (2001) J. Clin. Invest., 108, pp. 1123-1131
• Rosenfeld, M.G., Briata, P., Dasen, J., Gleiberman, A.S., Kioussi, C., Lin, C.J., O'Connell, S.M., Treier, M., Multistep signaling and transcriptional requirements for pituitary organogenesis in vivo (2000) Recent Prog. Horm. Res., 55, pp. 1-14
• Shen, E.S., Hardenburg, J.L., Meade, E.H., Arey, B.J., Merchenthaler, I., Lopez, F.J., Estradiol induces galanin gene expression in the pituitary of the mouse in an estrogen receptor alpha-dependent manner (1999) Endocrinology, 140, pp. 2628-2631
• Simmons, D.M., Voss, J.W., Ingraham, H.A., Holloway, J.M., Broide, R.S., Rosenfeld, M.G., Swanson, L.W., Pituitary cell phenotypes involve cell-specific Pit-1 mRNA translation and synergistic interactions with other classes of transcription factors (1990) Genes Dev., 4, pp. 695-711
• Tsukamoto, N., Otsuka, F., Miyoshi, T., Yamanaka, R., Inagaki, K., Yamashita, M., Otani, H., Makino, H., Effects of bone morphogenetic protein (BMP) on adrenocorticotropin production by pituitary corticotrope cells: involvement of up-regulation of BMP receptor signaling by somatostatin analogs (2010) Endocrinology, 151, pp. 1129-1141
• Vitt, U.A., Hsu, S.Y., Hsueh, A.J., Evolution and classification of cystine knot-containing hormones and related extracellular signaling molecules (2001) Mol. Endocrinol., 15, pp. 681-694
• Voss, J.W., Rosenfeld, M.G., Anterior pituitary development: short tales from dwarf mice (1992) Cell, 70, pp. 527-530
• vsian-Kretchmer, O., Hsueh, A.J., Comparative genomic analysis of the eight-membered ring cystine knot-containing bone morphogenetic protein antagonists (2004) Mol. Endocrinol., 18, pp. 1-12
• Wrana, J.L., Regulation of Smad activity (2000) Cell, 100, pp. 189-192

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------